Is RYPRX or MRK a better dividend investment in 2026?

RYPRX currently yields 11.86% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: RYPRX offers higher current income.

What is the dividend yield difference between RYPRX and MRK?

RYPRX has a forward dividend yield of 11.86% ($1.24/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 8.61 percentage points.

Home › Compare › RYPRX vs MRK

RYPRX vs MRK: Dividend Comparison 2026

RYPRX yields 11.86% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYPRX wins by $13.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

RYPRX

● Live price

11.86%

Share price

$10.46

Annual div

$1.24

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$43.7K

Annual income

$2,487.78

Full RYPRX calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — RYPRX vs MRK

📍 RYPRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RYPRX	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RYPRX + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RYPRX pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RYPRX

Annual income on $10K today (after 15% tax)

$1,008.30/yr

After 10yr DRIP, annual income (after tax)

$2,114.61/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, RYPRX beats the other by $1,306.87/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RYPRX + MRK for your $10,000?

RYPRX: 50%MRK: 50%

100% MRK50/50100% RYPRX

Portfolio after 10yr

$37.2K

Annual income

$1,719.04/yr

Blended yield

4.62%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RYPRX

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RYPRX buys

MRK buys

No recent congressional trades found for RYPRX or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRYPRXMRK

Forward yield	11.86% ✓	3.25%
Annual dividend / share	$1.24	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$43.7K ✓	$30.7K
Annual income after 10y	$2,487.78 ✓	$950.29
Total dividends collected	$18.2K ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: RYPRX vs MRK ($10,000, DRIP)

Year	RYPRX Portfolio	RYPRX Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$11,886	$1,186.23	$11,192	$351.54	+$694.00 → RYPRX
2	$14,036	$1,317.74	$12,524	$392.70	+$1.5K → RYPRX
3	$16,473	$1,454.27	$14,015	$438.65	+$2.5K → RYPRX
4	$19,221	$1,595.09	$15,682	$489.96	+$3.5K → RYPRX
5	$22,306	$1,739.45	$17,547	$547.23	+$4.8K → RYPRX
6	$25,754	$1,886.56	$19,632	$611.16	+$6.1K → RYPRX
7	$29,592	$2,035.68	$21,963	$682.53	+$7.6K → RYPRX
8	$33,850	$2,186.06	$24,571	$762.18	+$9.3K → RYPRX
9	$38,556	$2,336.99	$27,486	$851.08	+$11.1K → RYPRX
10	$43,743	$2,487.78	$30,745	$950.29	+$13.0K → RYPRX

RYPRX vs MRK: Complete Analysis 2026

RYPRX — Stock

The fund's investment adviser invests the fund's assets in a limited number (generally less than 100) of equity securities of primarily small-cap companies at the time of investment. Normally, the fund invests at least 80% of its net assets in equity securities of such premier companies. At least 65% of these securities will be issued by small-cap companies at the time of investment.

Full RYPRX Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this RYPRX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RYPRX vs SCHD RYPRX vs JEPI RYPRX vs O RYPRX vs KO RYPRX vs MAIN RYPRX vs JNJ RYPRX vs ABBV RYPRX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.